The role of the BCL-2 family of proteins in HIV-1 pathogenesis and persistence

Aswath P. Chandrasekar, Nathan W. Cummins, Andrew D. Badleya

Research output: Contribution to journalArticle

Abstract

Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape. One of the major regulators of apoptosis, the BCL-2 protein, alongside its homologous family members, is a major target of HIV-1-induced change. Recent studies have now demonstrated the association of this protein with cells that support proviral forms in the setting of latency and have helped identify BCL-2 as a novel and promising therapeutic target for HIV-1 therapy directed at possible cure. This review aims to systematically review the interactions of HIV-1 with BCL-2 and its homologs and to examine the possibility of using BCL-2 inhibitors in the study and elimination of the latent reservoir.

Original languageEnglish (US)
Article numbere00107-19
JournalClinical Microbiology Reviews
Volume33
Issue number1
DOIs
StatePublished - Jan 2020

Fingerprint

HIV-1
Proteins
Therapeutics
Apoptosis
Infection

Keywords

  • Antiapoptosis
  • Apoptosis
  • BCL-2 family
  • Human immunodeficiency virus

ASJC Scopus subject areas

  • Epidemiology
  • Immunology and Microbiology(all)
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

The role of the BCL-2 family of proteins in HIV-1 pathogenesis and persistence. / Chandrasekar, Aswath P.; Cummins, Nathan W.; Badleya, Andrew D.

In: Clinical Microbiology Reviews, Vol. 33, No. 1, e00107-19, 01.2020.

Research output: Contribution to journalArticle

@article{c456090fdc2c413eb881e19b1a05cdd7,
title = "The role of the BCL-2 family of proteins in HIV-1 pathogenesis and persistence",
abstract = "Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape. One of the major regulators of apoptosis, the BCL-2 protein, alongside its homologous family members, is a major target of HIV-1-induced change. Recent studies have now demonstrated the association of this protein with cells that support proviral forms in the setting of latency and have helped identify BCL-2 as a novel and promising therapeutic target for HIV-1 therapy directed at possible cure. This review aims to systematically review the interactions of HIV-1 with BCL-2 and its homologs and to examine the possibility of using BCL-2 inhibitors in the study and elimination of the latent reservoir.",
keywords = "Antiapoptosis, Apoptosis, BCL-2 family, Human immunodeficiency virus",
author = "Chandrasekar, {Aswath P.} and Cummins, {Nathan W.} and Badleya, {Andrew D.}",
year = "2020",
month = "1",
doi = "10.1128/CMR.00107-19",
language = "English (US)",
volume = "33",
journal = "Clinical Microbiology Reviews",
issn = "0893-8512",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - The role of the BCL-2 family of proteins in HIV-1 pathogenesis and persistence

AU - Chandrasekar, Aswath P.

AU - Cummins, Nathan W.

AU - Badleya, Andrew D.

PY - 2020/1

Y1 - 2020/1

N2 - Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape. One of the major regulators of apoptosis, the BCL-2 protein, alongside its homologous family members, is a major target of HIV-1-induced change. Recent studies have now demonstrated the association of this protein with cells that support proviral forms in the setting of latency and have helped identify BCL-2 as a novel and promising therapeutic target for HIV-1 therapy directed at possible cure. This review aims to systematically review the interactions of HIV-1 with BCL-2 and its homologs and to examine the possibility of using BCL-2 inhibitors in the study and elimination of the latent reservoir.

AB - Advances in HIV-1 therapy have transformed the once fatal infection into a manageable, chronic condition, yet the search for a widely applicable approach to cure remains elusive. The ineffectiveness of antiretroviral therapy (ART) in reducing the size of the HIV-1 latent reservoir has prompted investigation into the mechanisms of HIV-1 latency and immune escape. One of the major regulators of apoptosis, the BCL-2 protein, alongside its homologous family members, is a major target of HIV-1-induced change. Recent studies have now demonstrated the association of this protein with cells that support proviral forms in the setting of latency and have helped identify BCL-2 as a novel and promising therapeutic target for HIV-1 therapy directed at possible cure. This review aims to systematically review the interactions of HIV-1 with BCL-2 and its homologs and to examine the possibility of using BCL-2 inhibitors in the study and elimination of the latent reservoir.

KW - Antiapoptosis

KW - Apoptosis

KW - BCL-2 family

KW - Human immunodeficiency virus

UR - http://www.scopus.com/inward/record.url?scp=85074320261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074320261&partnerID=8YFLogxK

U2 - 10.1128/CMR.00107-19

DO - 10.1128/CMR.00107-19

M3 - Article

C2 - 31666279

AN - SCOPUS:85074320261

VL - 33

JO - Clinical Microbiology Reviews

JF - Clinical Microbiology Reviews

SN - 0893-8512

IS - 1

M1 - e00107-19

ER -